NSE:MARKSANS
Marksans Pharma Limited
- Stock
Last Close
165.95
06/05 10:00
Market Cap
65.05B
Beta: 1.23
Volume Today
1.57M
Avg: 2.09M
PE Ratio
22.85
PFCF: -
Dividend Yield
0.33%
Payout:0%
Mar '14 | Mar '15 | Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
net income | 719.08M - | 1.09B 52.13% | 1.07B 2.33% | 155.29M 85.47% | 497.98M 220.67% | 1.04B 109.46% | 1.57B 50.68% | 3.02B 92.25% | 2.48B 18.09% | 3.38B 36.42% | |
depreciation and amortization | 156.91M - | 161.34M 2.82% | 281.27M 74.33% | 300.93M 6.99% | 268.38M 10.82% | 228.04M 15.03% | 266.62M 16.92% | 361.51M 35.59% | 447.76M 23.86% | 518.53M 15.81% | |
deferred income tax | |||||||||||
stock based compensation | |||||||||||
change in working capital | -260.10M - | 208.52M 180.17% | -841.64M 503.62% | -241.00M 71.37% | -273.96M 13.68% | -817.92M 198.56% | 357.34M 143.69% | -1.50B 519.85% | -1.11B 26.21% | -1.11B 0.69% | |
accounts receivables | 3.09M - | -667.55M 21,728.79% | -367.44M 44.96% | -1.04B 182.86% | -275.18M 73.52% | ||||||
inventory | -248.97M - | -275.18M 10.53% | -376.85M 36.95% | -222.95M 40.84% | -280.37M 25.75% | -751.22M 167.94% | 514.02M 168.42% | -1.62B 416.09% | -178.49M 89.01% | -448.50M 151.27% | |
accounts payables | 90.37M - | 665.73M 636.70% | 417.84M 37.24% | 184.90M 55.75% | 224.23M 21.27% | ||||||
other working capital | -11.13M - | 483.70M 4,443.99% | -464.79M 196.09% | -18.04M 96.12% | 6.41M 135.55% | -160.15M 2,596.89% | -154.87M 3.30% | 74.08M 147.83% | -74.09M 200.01% | -615.20M 730.34% | |
other non cash items | 32.50M - | 81.31M 150.14% | -200.13M 346.14% | -126.80M 36.64% | 96.80M 176.34% | -179.23M 285.17% | -96.23M 46.31% | -95.47M 0.80% | -823.28M 762.37% | -406.29M 50.65% | |
net cash provided by operating activities | 648.39M - | 1.55B 138.30% | 308.00M 80.07% | 88.42M 71.29% | 589.20M 566.34% | 273.95M 53.50% | 2.10B 666.36% | 1.79B 14.86% | 992.57M 44.47% | 2.37B 139.19% | |
investments in property plant and equipment | -364.66M - | -1.32B 261.64% | -277.49M 78.96% | -389.35M 40.31% | -131.47M 66.23% | -596.27M 353.55% | -464.24M 22.14% | -463.30M 0.20% | -536.31M 15.76% | ||
acquisitions net | -52.08M - | 2.82M - | 5.20M 84.38% | 340K 93.46% | -266.10M 78,364.71% | ||||||
purchases of investments | -1.50M - | -1.90B 126,410.67% | |||||||||
sales maturities of investments | 951.63K - | -340K - | 2.16B 636,500.00% | ||||||||
other investing activites | 7.20M - | 32.76M 355.05% | 88.63M 170.52% | 69.05M 22.09% | 1.56M 97.74% | -4.28M 374.67% | -1.85M 56.71% | 10.08M 643.89% | 47.94M 375.54% | -2.06B 4,388.30% | |
net cash used for investing activites | -44.88M - | -331.89M 639.51% | -1.23B 270.64% | -208.44M 83.06% | -387.79M 86.05% | -134.80M 65.24% | -595.30M 341.63% | -448.96M 24.58% | -416.86M 7.15% | -2.59B 521.82% | |
debt repayment | -84.65M - | -998.67M 1,079.82% | -334.97M 66.46% | -66.78M - | -703.05M 952.84% | -1.03M 99.85% | -225.52M 21,898.75% | -2.30B 917.84% | |||
common stock issued | 1.31B - | 703.05M - | 911.55M - | 2.75B 201.36% | |||||||
common stock repurchased | -10M - | -15M - | -10M 33.33% | -50M - | -225.52M - | -451.66M 100.27% | |||||
dividends paid | -104.24M - | -69.72M 33.12% | -179.61M 157.63% | -145.30M 19.10% | -24.63M 83.05% | -44.44M 80.42% | -295.03M 563.87% | -40.93M 86.13% | -105.83M 158.55% | -101.71M 3.89% | |
other financing activites | -103.96M - | -64.10M 38.34% | -62.94M 1.80% | 178.92M 384.25% | -19.63M 110.97% | -96.55M 391.84% | -556.45M 476.31% | -110.90M 80.07% | 440.43M 497.13% | 2.08B 372.27% | |
net cash used provided by financing activities | -292.84M - | 169.94M 158.03% | -577.53M 439.83% | 18.62M 103.22% | -54.26M 391.43% | -207.77M 282.90% | -901.48M 333.88% | -152.86M 83.04% | 795.11M 620.16% | 1.98B 148.81% | |
effect of forex changes on cash | 6.06M - | -1.03M 117.02% | -1.43B 138,303.25% | 20K 100.00% | |||||||
net change in cash | 310.67M - | 1.38B 345.22% | -1.50B 208.42% | -101.39M 93.24% | 147.15M 245.13% | -68.62M 146.63% | 602.66M 978.29% | 1.19B 96.73% | 1.37B 15.62% | 1.76B 28.41% | |
cash at beginning of period | 158.80M - | 469.47M 195.64% | 1.85B 294.63% | 353.01M 80.95% | 251.62M 28.72% | 397.17M 57.84% | 328.55M 17.28% | 937.27M 185.28% | 2.12B 126.38% | 2.06B 2.72% | |
cash at end of period | 469.47M - | 1.85B 294.63% | 353.01M 80.95% | 251.62M 28.72% | 398.77M 58.48% | 328.55M 17.61% | 931.21M 183.43% | 2.12B 127.97% | 3.49B 64.53% | 3.82B 9.50% | |
operating cash flow | 648.39M - | 1.55B 138.30% | 308.00M 80.07% | 88.42M 71.29% | 589.20M 566.34% | 273.95M 53.50% | 2.10B 666.36% | 1.79B 14.86% | 992.57M 44.47% | 2.37B 139.19% | |
capital expenditure | -364.66M - | -1.32B 261.64% | -277.49M 78.96% | -389.35M 40.31% | -131.47M 66.23% | -596.27M 353.55% | -464.24M 22.14% | -463.30M 0.20% | -536.31M 15.76% | ||
free cash flow | 648.39M - | 1.18B 82.06% | -1.01B 185.62% | -189.06M 81.29% | 199.85M 205.71% | 142.49M 28.70% | 1.50B 954.97% | 1.32B 11.97% | 529.27M 60.00% | 1.84B 247.23% |
All numbers in INR (except ratios and percentages)